[go: up one dir, main page]

BE901810A - BROMOCRIPTINE COMPOSITIONS. - Google Patents

BROMOCRIPTINE COMPOSITIONS.

Info

Publication number
BE901810A
BE901810A BE1/11199A BE1011199A BE901810A BE 901810 A BE901810 A BE 901810A BE 1/11199 A BE1/11199 A BE 1/11199A BE 1011199 A BE1011199 A BE 1011199A BE 901810 A BE901810 A BE 901810A
Authority
BE
Belgium
Prior art keywords
bromocriptine
pharmacies
acceptable
compositions
bromocriptine compositions
Prior art date
Application number
BE1/11199A
Other languages
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of BE901810A publication Critical patent/BE901810A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Composition à libération controlée pour l'administration orale de la bromocriptine,(2-bromo-12'-hydroxy-2'-(1-méthyléthyl)-5'alpha-(2-méthylpropyl) ergotamine-3',6'-trione), une substance gonflante hydrophile acceptable en pharmacie et une matière grasse inerte acceptable en pharmacie.Controlled release composition for oral administration of bromocriptine, (2-bromo-12'-hydroxy-2 '- (1-methylethyl) -5'alpha- (2-methylpropyl) ergotamine-3', 6'-trione ), a hydrophilic swelling substance acceptable in pharmacies and an inert fat acceptable in pharmacies.

BE1/11199A 1984-02-29 1985-02-25 BROMOCRIPTINE COMPOSITIONS. BE901810A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848405227A GB8405227D0 (en) 1984-02-29 1984-02-29 Bromocriptine compositions

Publications (1)

Publication Number Publication Date
BE901810A true BE901810A (en) 1985-08-26

Family

ID=10557324

Family Applications (1)

Application Number Title Priority Date Filing Date
BE1/11199A BE901810A (en) 1984-02-29 1985-02-25 BROMOCRIPTINE COMPOSITIONS.

Country Status (26)

Country Link
JP (1) JPS60202812A (en)
AT (1) AT387716B (en)
AU (2) AU586621B2 (en)
BE (1) BE901810A (en)
CA (1) CA1256374A (en)
CH (2) CH666406A5 (en)
DE (1) DE3505743C2 (en)
DK (1) DK175016B1 (en)
ES (1) ES8705223A1 (en)
FR (1) FR2560047B1 (en)
GB (1) GB8405227D0 (en)
GR (1) GR850506B (en)
HK (1) HK85490A (en)
HU (1) HU196121B (en)
IE (1) IE58235B1 (en)
IL (1) IL74459A (en)
IT (1) IT1199948B (en)
LU (1) LU85791A1 (en)
MX (1) MX9203626A (en)
NL (1) NL194231C (en)
NZ (1) NZ211247A (en)
PH (1) PH23266A (en)
PT (1) PT80015B (en)
SE (2) SE8500961L (en)
SG (1) SG69390G (en)
ZA (1) ZA851546B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61501511A (en) * 1984-03-21 1986-07-24 アメリカン・ホ−ム・プロダクツ・コ−ポレイション sustained release pharmaceutical capsules
DE3722383A1 (en) * 1986-07-14 1988-01-28 Sandoz Ag NEW USE OF BROMOCRIPTIN
DE4041563A1 (en) * 1990-12-22 1992-06-25 Sanol Arznei Schwarz Gmbh METHOD FOR PRODUCING ACTIVE MICROPARTICLES FROM HYDROLYTICALLY DEGRADABLE POLYMERS
WO1994021229A1 (en) * 1993-03-17 1994-09-29 Minnesota Mining And Manufacturing Company Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL128902C (en) * 1960-06-06
CH507249A (en) * 1968-05-31 1971-05-15 Sandoz Ag Process for the preparation of 2-bromo-a-ergocryptine
DE2553026A1 (en) * 1974-12-04 1976-06-10 Schlueter Edelfett Compressible tablet formulations - contg branched fatty alcohols and/or fatty acid triglycerides and/or fatty alcohol esters as hydrophobic carrier materials
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
IT1158162B (en) * 1977-12-22 1987-02-18 Sandoz Ag PHARMACEUTICAL COMPOSITIONS BASED ON DERIVATIVES OF ERGOLENA AND ERGOLINA
DE3045135A1 (en) * 1980-11-29 1982-06-09 Sandoz-Patent-GmbH, 7850 Lörrach BODEGRADABLE POLYMERS CONTAINING PHARMACEUTICAL COMPOSITIONS
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
DE3216870A1 (en) * 1982-05-03 1983-11-03 Schering AG, 1000 Berlin und 4709 Bergkamen PHARMACEUTICAL PREPARATIONS WITH A CYTOSTATIC EFFECT
US4559222A (en) * 1983-05-04 1985-12-17 Alza Corporation Matrix composition for transdermal therapeutic system

Also Published As

Publication number Publication date
PT80015A (en) 1986-02-10
DK86785D0 (en) 1985-02-26
HU196121B (en) 1988-10-28
FR2560047B1 (en) 1988-01-15
SG69390G (en) 1990-10-26
NL8500417A (en) 1985-09-16
AT387716B (en) 1989-03-10
DK86785A (en) 1985-08-30
PT80015B (en) 1987-09-18
SE8500961L (en) 1985-08-30
AU3913685A (en) 1985-09-05
ATA58085A (en) 1988-08-15
CA1256374A (en) 1989-06-27
IL74459A (en) 1988-12-30
LU85791A1 (en) 1985-12-11
ZA851546B (en) 1986-10-29
JPS60202812A (en) 1985-10-14
GR850506B (en) 1985-06-28
FR2560047A1 (en) 1985-08-30
IT1199948B (en) 1989-01-05
CH667009A5 (en) 1988-09-15
AU618599B2 (en) 1992-01-02
AU586621B2 (en) 1989-07-20
ES540807A0 (en) 1987-05-01
CH666406A5 (en) 1988-07-29
IL74459A0 (en) 1985-05-31
SE462259B (en) 1990-05-28
PH23266A (en) 1989-06-23
GB8405227D0 (en) 1984-04-04
NL194231C (en) 2001-10-02
IE850495L (en) 1985-08-29
AU3500689A (en) 1989-09-14
IE58235B1 (en) 1993-08-11
DE3505743C2 (en) 1995-02-16
HK85490A (en) 1990-10-25
SE8500961D0 (en) 1985-02-27
MX9203626A (en) 1992-09-01
IT8547703A1 (en) 1986-08-20
NZ211247A (en) 1989-02-24
ES8705223A1 (en) 1987-05-01
DK175016B1 (en) 2004-04-26
NL194231B (en) 2001-06-01
HUT38254A (en) 1986-05-28
JPH0448776B2 (en) 1992-08-07
DE3505743A1 (en) 1985-08-29
IT8547703A0 (en) 1985-02-20

Similar Documents

Publication Publication Date Title
ES2042561T3 (en) A PROCESS FOR THE PREPARATION OF A CONTROLLED RELEASE SOLID PHARMACEUTICAL COMPOSITION FOR ORAL, RECTAL OR VAGINAL ADMINISTRATION.
DE3583799D1 (en) SOLID PREPARATION WITH SLOW RELEASE.
MC1915A1 (en) Processes for the preparation of 2 ', 3'-dideoxynucleosides and pharmaceutical formulations containing them
ES2192226T3 (en) ORAL PHARMACEUTICAL COMPOSITION CONTAINING ANTIMICROBIAL ACTIVE AGENTS AND PROLONGED LIBERATION PANTOPRAZOL.
DZ1078A1 (en) Pharmaceutical formulation of acid labile substance for oral administration.
DE68903442D1 (en) SOLID AND POROUS UNIT, CONTAINING MICROPARTICLES AND / OR NANOPARTICLES, AND METHOD FOR THE PRODUCTION THEREOF.
ES8608864A1 (en) Sheet-like preparation
NL194821B (en) Pharmacologically active catechol derivatives and their compositions.
DE3379496D1 (en) Constant release rate solid oral dosage formulations of cardiovascular drugs
ES2032770T3 (en) A PROCEDURE FOR PRODUCING NASAL ADMINISTRATION DRUGS.
DZ1077A1 (en) New pharmaceutical preparation for oral administration.
MY101544A (en) Pharmaceutical composition for external use containing active-type vitamin d3.
IT8619675A0 (en) FORMULATIONS FOR THE PREPARATION OF PROLONGED-RELEASE DRUGS SUITABLE FOR ORAL ADMINISTRATION.
OA06533A (en) Pyrimidine derivatives, processes for their preparation, pharmaceutical compositions containing these compounds and their therapeutic use.
IL72539A (en) Alpha-(1-thio,sulfinyl or sulfonyl substituted alkenyl)benzyl alcohol derivatives,their preparation and pharmaceutical compositions containing them
DK0697814T3 (en) Pour-on formulations containing polymeric material glycols and glycerides
MY101029A (en) Bromocriptine compositions
BE901810A (en) BROMOCRIPTINE COMPOSITIONS.
SE8400723L (en) PHARMACEUTICAL COMPOSITION
OA09137A (en) New derivatives of benzoxazolinone, their preparation processes and pharmaceutical compositions containing them.
BE904152A (en) SUSTAINED RELEASE FORMULATION CONTAINING Rye ergot alkaloids.
FR2571369B1 (en) VITAMIN D DERIVATIVES AND PRECURSORS THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
IE831030L (en) Benzopyrans and benzothiopyrans
FR2599039B1 (en) NEW IMMUNO-SUPPRESSIVE SUBSTANCE, ITS PREPARATION BY CULTURE OF STREPTOMYCES SP. (CBS 162.86) AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING IT
DE3783923D1 (en) AN ACTIVE SUBSTANCE AND A MEDICINAL PRODUCT CONTAINING WATER SWELLING POLYMER.

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: *NOVARTIS A.G.

Effective date: 20050225

RE20 Patent expired

Owner name: *NOVARTIS A.G.

Effective date: 20050225